4//SEC Filing
Plesha Scott M. 4
Accession 0001103021-21-000016
CIK 0001103021other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 6:17 PM ET
Size
10.6 KB
Accession
0001103021-21-000016
Insider Transaction Report
Form 4
Plesha Scott M.
President
Transactions
- Exercise/Conversion
Common Stock
2021-01-29+10,870→ 244,873 total - Exercise/Conversion
Restricted Stock Units
2021-01-29−10,870→ 21,739 totalExercise: $0.00Exp: 2023-01-29→ Common Stock (10,870 underlying) - Exercise/Conversion
Common Stock
2021-02-01+13,333→ 258,206 total - Exercise/Conversion
Restricted Stock Units
2021-02-01−13,333→ 13,334 totalExercise: $0.00Exp: 2022-01-31→ Common Stock (13,333 underlying)
Footnotes (2)
- [F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units ("RSUs") granted to the Reporting Person on January 29, 2020, under the Issuer's 2019 Stock Option Incentive Plan. The remaining RSUs vest equally on January 29, 2022 and January 29, 2023.
- [F2]The shares of common stock were acquired by the Reporting Person as a result of the vesting of RSUs granted to the Reporting Person on January 31, 2019, under the Issuer's 2011 Equity Incentive Plan, as amended. The remaining RSUs will vest on January 31, 2022.
Documents
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC
CIK 0001103021
Entity typeother
Related Parties
1- filerCIK 0001726687
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 6:17 PM ET
- Size
- 10.6 KB